Robert Clarke MD, MRCP, FRCP, FFPH

Robert Clarke is an Emeritus Professor of Epidemiology and Public Health Medicine at the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Honorary Consultant in Public Health Medicine, and Scientific Director of the MSc in Global Health Science and Epidemiology. He qualified in clinical medicine in Ireland and worked for five years in internal medicine and four years in cardiology. After two years in clinical pharmacology at Vanderbilt University, Nashville, USA, he joined CTSU in 1991 and specialized in cardiovascular epidemiology.

His main research interests are to understand the importance of classical and novel risk factors for cardiovascular diseases. He worked on analyses of observational studies and trials in the UK and meta-analyses of international consortia of observational studies, genome-wide association studies, and randomized trials for heart disease and stroke. Over the last decade, his research work has focussed on understanding the causes of stroke and heart disease (ischaemic heart disease and heart failure) in the China Kadoorie Biobank. His research work in CKB includes studies of the diagnostic accuracy, prognosis, treatment, risk prediction, and evaluation of genetic and plasma biomarkers for stroke types and ischaemic heart disease and heart failure in CKB and related studies in NDPH and international consortia.

He is a member of the Strategic Oversight Committee for NDPH, the International Steering Committee of CKB, the Research Strategy and Management Committee of CKB, and the Co-chair of the International Research Management Committee of CKB.